EAGLE MATERIALS INC — Director's Dealing 2022

Jun 6, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: EAGLE MATERIALS INC (EXP)
CIK: 0000918646
Period of Report: 2022-06-03

Reporting Person: Newby Matt (EVP & General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17934	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (Right to Buy)	$75.69	2026-05-20	Common Stock (4246)		Direct
Non-Qualified Stock Option (Right to Buy)	$100.88	2027-05-18	Common Stock (3008)		Direct
Non-Qualified Stock Option (Right to Buy)	$100.88	2027-05-18	Common Stock (2605)		Direct
Non-Qualified Stock Option (Right to Buy)	$106.24	2028-05-17	Common Stock (3165)		Direct
Non-Qualified Stock Option (Right to Buy)	$106.24	2028-05-17	Common Stock (2940)		Direct
Non-Qualified Stock Option (Right to Buy)	$91.58	2029-05-16	Common Stock (3859)		Direct
Non-Qualified Stock Option (Right to Buy)	$91.58	2029-05-16	Common Stock (3654)		Direct
Non-Qualified Stock Option (Right to Buy)	$60.21	2030-05-19	Common Stock (2718)		Direct
Non-Qualified Stock Option (Right to Buy)	$60.21	2030-05-19	Common Stock (2265)		Direct

Footnotes

F1: This number includes the following restricted shares: (a) 561 shares remaining from a grant awarded to the reporting person on 5/16/2019, the restrictions on which will lapse on 3/31/2023; (b) 2,740 shares remaining from a grant awarded to the reporting person on 5/19/2020, the restrictions on which will lapse ratably on March 31 of 2023 and 2024; (c) 2,370 shares remaining from a grant awarded to the reporting person on 5/19/2021, the restrictions on which will lapse ratably on March 31 of 2023, 2024 and 2025; and (d) 2,773 shares awarded to the reporting person on 5/19/2022, the restrictions on which will lapse ratably on March 31 of 2023, 2024, 2025 and 2026.

F2: On May 20, 2016, the reporting person was granted an option to purchase up to 4,308 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2017. On May 10, 2017, the performance conditions were determined to have been satisfied such that stock options vested as to 4,246 shares and currently all of these options are exercisable.

F3: On May 18, 2017, the reporting person was granted an option to purchase up to 3,126 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2018. On May 7, 2018, the performance conditions were determined to have been satisfied such that stock options vested as to 3,008 shares and currently all of these options are exercisable.

F4: On May 18, 2017 the reporting person was granted an option to purchase up to 2,605 shares of Common Stock, and currently all of these options are exercisable.

F5: On May 17, 2018, the reporting person was granted an option to purchase up to 3,528 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2019. On May 13, 2019, the performance conditions were determined to have been satisfied such that stock options vested as to 3,165 shares, all of which are currently exercisable.

F6: On May 17, 2018 the reporting person was granted an option to purchase up to 2,940 shares of Common Stock, and currently all of these options are exercisable.

F7: On May 16, 2019, the reporting person was granted an option to purchase up to 4,385 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2020. On May 4, 2020, the performance conditions were determined to have been satisfied such that stock options vested as to 3,859 shares. Currently 2,895 options are exercisable and the remaining options vest on March 31, 2023.

F8: On May 16, 2019 the reporting person was granted an option to purchase up to 3,654 shares of Common Stock, Currently 2,741 options are exercisable and the remaining options will vest on March 31, 2023.

F9: On May 19, 2020, the reporting person was granted an option to purchase up to 2,718 shares of Common Stock subject to the achievement by the Company of certain performance vesting criteria measured at the end of fiscal 2021. On May 6, 2021, the performance conditions were determined to have been satisfied such that stock options vested as to 2,718 shares. Currently 1,360 options are exercisable and the remaining options vest on March 31 of 2023 and 2024.

F10: On May 19, 2020 the reporting person was granted an option to purchase up to 2,265 shares of Common Stock, Currently 1,133 options are exercisable and the remaining options will vest ratably on March 31 of 2023 and 2024.